Jan. 4, 2024

W. Kimryn Rathmell, MD, assumed the role of director of the National Cancer Institute (NCI) Dec. 18. NCI is one of the 27 institutes and centers of the National Institutes of Health (NIH). It is the federal government’s principal agency for cancer research and training, and the largest funder of cancer research in the world with a current fiscal year 2023 budget of $7.3 billion.

President Biden announced his intention to nominate Rathmell to succeed Monica Bertagnolli, MD, who was confirmed as the NIH director Nov. 9.

Rathmell comes to NCI from Vanderbilt University Medical Center, where she was the physician-in-chief and the chair of the department of medicine. Her past research focused on the underlying drivers of kidney cancers by using genetic, molecular and cell biology to develop robust approaches to improve patient outcomes. Rathmell is the second woman to hold the post.

The American College of Radiology® (ACR®) continues to encourage imaging as a priority in Dr. Rathmell’s role as NCI director and welcomes the opportunity for future collaborations.

For more information, contact Katie Grady, ACR Government Affairs Director.


Related ACR News

  • Radiology’s Fight Against Prior Authorization Delays

    ACR is leading national efforts to make prior authorization more efficient and clinically appropriate while reducing the administrative burden and supporting national legislation.

    Read more
  • ACR Supports Medicaid Coverage of Lung Cancer Screening

    ACR-backed bill would mandate Medicaid lung cancer screening, expand cessation coverage, ban prior auth—aiming to save lives and reduce disparities.

    Read more
  • Patient-Centered Imaging Care Led by Radiologists

    ACR helps its state chapters fight scope of practice expansion, such as helping to oppose bills in state legislatures that would allow non-physicians to practice independently.

    Read more